{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:19:49Z","timestamp":1788211189393,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.avsg.2026.06.047","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:19:51Z","timestamp":1784042391000},"page":"662-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and Safety of Rivaroxaban in Patients with Peripheral Artery Disease: A GRADE-assessed Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"132","author":[{"given":"Muhammad","family":"Shahzaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3410-9759","authenticated-orcid":false,"given":"Muhammad","family":"Roshaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Khan","family":"Buhadur Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ibad","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noraiz Abbas","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata Ul","family":"Haiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadeeja Ali","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahryar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimra","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizza","family":"Liaqat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Haseeb","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2026.06.047_bib1","first-page":"26","article-title":"Peripheral arterial disease: pathophysiology, risk factors, diagnosis, treatment, and prevention","volume":"27","author":"Muir","year":"2009","journal-title":"J Vasc Nurs Off Publ Soc Peripher Vasc Nurs"},{"key":"10.1016\/j.avsg.2026.06.047_bib2","first-page":"0702","article-title":"Forecasting the Global Burden of Peripheral Artery Disease from 2021 to 2050: a Population-Based Study","volume":"8","author":"Deng","year":"2025","journal-title":"Res Wash DC"},{"key":"10.1016\/j.avsg.2026.06.047_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/VHRM.S501096","article-title":"Prevalence and risk factors of peripheral artery disease in diabetic patients: insights from a retrospective cross-sectional and cohort study in Abu Dhabi","volume":"21","author":"Alyahyaee","year":"2025","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2026.06.047_bib4","article-title":"Peripheral artery disease as a risk factor for myocardial infarction","volume":"13","author":"P\u00e9rez","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.avsg.2026.06.047_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.927645","article-title":"Antithrombotic therapy in peripheral arterial disease","volume":"9","author":"Espinola-Klein","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.avsg.2026.06.047_bib6","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.06.047_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1177\/08971900241250084","article-title":"Management and pharmacological treatment of peripheral arterial disease","volume":"37","author":"Leatham","year":"2024","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.avsg.2026.06.047_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118589","article-title":"Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: the RESRISK cohort study","volume":"398","author":"Vallejo-Vaz","year":"2024","journal-title":"Atherosclerosis"},{"issue":"Supplement_1","key":"10.1016\/j.avsg.2026.06.047_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.2546","article-title":"Atherothrombotic residual risk in coronary and peripheral artery disease patients on guideline-recommended antiplatelet monotherapy: baseline preliminary results from the RESRISK study","volume":"42","author":"Vallejo-Vaz","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2026.06.047_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/17085381241237005","article-title":"Optimizing platelet inhibition in peripheral artery disease: a comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography","volume":"33","author":"Lee","year":"2025","journal-title":"Vascular"},{"key":"10.1016\/j.avsg.2026.06.047_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","article-title":"The mechanism of action of rivaroxaban \u2013 an oral, direct Factor Xa inhibitor \u2013 compared with other anticoagulants","volume":"127","author":"Samama","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2026.06.047_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","article-title":"Rivaroxaban: a new oral factor Xa inhibitor","volume":"30","author":"Perzborn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2026.06.047_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2026.06.047_bib14","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.06.047_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/15385744211012916","article-title":"Efficacy and safety of rivaroxaban therapy for patients with peripheral artery disease: a systematic review and meta-analysis","volume":"55","author":"Hao","year":"2021","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2026.06.047_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.avsg.2026.06.047_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","article-title":"PROSPERO: an international register of systematic review protocols","volume":"38","author":"Schiavo","year":"2019","journal-title":"Med Ref Serv Q"},{"key":"10.1016\/j.avsg.2026.06.047_bib18","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.avsg.2026.06.047_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.avsg.2026.06.047_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2023.1285553","article-title":"Rivaroxaban plus aspirin vs. dual antiplatelet therapy in endovascular treatment in peripheral artery disease and analysis of medication utilization of different lesioned vascular regions","volume":"10","author":"Huo","year":"2023","journal-title":"Front Surg"},{"issue":"3","key":"10.1016\/j.avsg.2026.06.047_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ehjcvp\/pvz047","article-title":"Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease","volume":"6","author":"Coleman","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.avsg.2026.06.047_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/ehjcvp\/pvaf063","article-title":"Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease","volume":"11","author":"Dari","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.avsg.2026.06.047_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/jcdd10020065","article-title":"Direct oral anticoagulants as the first choice of anticoagulation for patients with peripheral artery disease to prevent adverse vascular events: a systematic review and meta-analysis","volume":"10","author":"Pomozi","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.avsg.2026.06.047_bib21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jvs.2024.01.196","article-title":"Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia","volume":"79","author":"Rockhold","year":"2024","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.06.047_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1024\/0301-1526\/a001193","article-title":"Warfarin and DOAC impact on cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"54","author":"Apolinario","year":"2025","journal-title":"VASA Z Gefasskrankheiten"},{"key":"10.1016\/j.avsg.2026.06.047_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14796678.2025.2522587","article-title":"Systematic review of the use of oral anticoagulants in patients with peripheral arterial disease","volume":"21","author":"Naqvi","year":"2025","journal-title":"Future Cardiol"},{"key":"10.1016\/j.avsg.2026.06.047_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0741-5214(99)70219-3","article-title":"Quality of life after infrainguinal bypass grafting surgery","volume":"29","author":"Tangelder","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.06.047_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11886-019-1198-5","article-title":"Rivaroxaban and aspirin in peripheral vascular disease: a review of implementation strategies and management of common clinical scenarios","volume":"21","author":"McClure","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.avsg.2026.06.047_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.avsg.2026.06.047_bib27","author":"Sibbing"},{"key":"10.1016\/j.avsg.2026.06.047_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurheartj\/eht492","article-title":"Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF","volume":"35","author":"Jones","year":"2014","journal-title":"Eur Heart J"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626004991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626004991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:38:06Z","timestamp":1788208686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509626004991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S0890509626004991"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2026.06.047","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Rivaroxaban in Patients with Peripheral Artery Disease: A GRADE-assessed Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2026.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}